Neurology · 2001 · 115 citations · 6 references
MedicinePharmacologyPharmacotherapyClinical NeuroscienceEpilepsyNeuropharmacologyAntiepileptic PharmacologyAntiepileptic PharmacotherapySeizure DisordersSeizure ManagementLevetiracetam TherapyLevetiracetam TreatmentLevetiracetam-based TherapyMyoclonic SeizuresOpen-label PlaceboOpen-label TrialsPlacebo-controlled Efficacy AssessmentSeizures
Levetiracetam was recently approved as adjunctive therapy for partial onset seizures. The authors conducted an open-label trial of levetiracetam in eight patients with chronic myoclonus. Patients were assessed by using the Unified Myoclonus Rating Scale. Levetiracetam was well tolerated. Three of five patients with cortical myoclonus experienced reductions in their myoclonus scores, providing support for a larger, placebo-controlled trial in cortical myoclonus.
6
Levetiracetam for partial seizures
James J. Cereghino, Victor Biton, Bassel Abou‐Khalil et al. · Neurology · 2000 · 524 citations
Marjaleena Koskiniemi, Betty Van Vleymen, L. Hakamies et al. · Journal of Neurology Neurosurgery & Psychiatry · 1998 · 109 citations · Full text
Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam
Gregory L. Krauss, Ann M. Bergin, Ronald E. Kramer et al. · Neurology · 2001 · 102 citations
Medicine, Neurology, Pharmacology +14